---
sidebar_position: 71
---

# æ–‡ç» 71ï¼šExploring Young Adults' Experiences and Beliefs in Asthma Medication Management: Pilot Qualitative Study

**English Title**: Exploring Young Adults' Experiences and Beliefs in Asthma Medication Management: Pilot Qualitative Study

**ä¸­æ–‡æ¨™é¡Œ**: æ¢ç´¢å¹´è¼•æˆå¹´äººåœ¨å“®å–˜è—¥ç‰©ç®¡ç†ä¸­çš„ç¶“é©—å’Œä¿¡å¿µï¼šå…ˆå°å®šæ€§ç ”ç©¶
**PMID**: 40815807
**æœŸåˆŠ**: æœªçŸ¥æœŸåˆŠ
**è©•åˆ†**: ä¸­ç­‰
**æ‡‰ç”¨é ˜åŸŸ**: 7
**DOI**: https://doi.org/10.2196/69892

---

## ğŸ“Œ ç¬¬ä¸€å¼µï¼šæ ¸å¿ƒè§€é»å¡

### ä¸»è¦ç™¼ç¾
ä¸­ç­‰

### æ–‡ç»æ‘˜è¦ï¼ˆAbstractï¼‰
BACKGROUND: Young adults take their asthma maintenance medication 67% of the time or less. Understanding the specific needs and behaviors of young adults with asthma is essential for developing targeted interventions to improve disease self-management. Artificial intelligence (AI) has demonstrated its utility in summarizing and identifying patterns in qualitative research and may support or augment human coding efforts. However, there is pause literature to support this assertion. OBJECTIVE: The objective of this study is to begin to explore the medication management-related needs of young adults with asthma via a pilot feasibility study. We aim to understand how to best assist young adults with asthma self-management and to identify potential areas where digital health interventions can provide support. We further aimed to understand the comparative outcome of human versus multiple AI platforms in performing thematic analysis. METHODS: This study purposefully sampled young adults between the ages of 18 years and 29 years who had a prescription for an inhaled corticosteroid (ICS) and were either students or staff of a large metropolitan university in the northeastern United States. Semistructured interviews lasting 40 minutes on average were conducted with 4 participants via a teleconferencing application to elicit young adults' opinions on the topic. Interviews were recorded and transcribed verbatim using Otter.ai (Otter.ai, Inc). Investigators listened to the recording to confirm the accuracy of transcriptions and to make corrections when necessary. After performing a second round of line-by-line coding, the codes were reviewed by investigators and grouped into broader, overarching themes. All investigators reviewed and discussed the final codes. Human qualitative data analyses were performed using NVivo 14 software (QSR International). After completing human analyses, the investigators performed thematic analysis with multiple AI platforms (Google Gemini, Microsoft Copilot, and OpenAI's ChatGPT) to compare the final themes with investigator-derived themes. RESULTS: Human analysis yielded 4 themes: support from clinicians, social support, digital self-management support, and educational support. The AI-based analysis also generated similar themes with different labels. The level of overlap on the underlying concept between humans, Gemini, Copilot, and ChatGPT was high, accounting for the fact that, although the specific labels differed, they referred to the same concept. CONCLUSIONS: Findings from our pilot exploratory study offer insights into the necessity for a holistic approach in supporting young adults with asthma. Based on the health belief model, if the identified multifaceted needs are addressed, health care systems may support medication adherence and improve health outcomes for this understudied patient population. Our pilot study also offers preliminary findings that artificial intelligence may be leveraged for successful thematic analysis of qualitative data with appropriate caution.

### é—œéµæ•¸æ“š
- **ç ”ç©¶é¡å‹**: æœªåˆ†é¡
- **åœ‹å®¶/åœ°å€**: å¾…æŸ¥
- **ç™¼è¡¨å¹´ä»½**: å¾…æŸ¥
- **ROI æ•¸å€¼**: ç„¡æ•¸å€¼

### æ ¸å¿ƒå‰µæ–°é»
æœ¬ç ”ç©¶çš„ä¸»è¦å‰µæ–°åœ¨æ–¼ï¼šä¸­ç­‰

---

## âœï¸ ç¬¬äºŒå¼µï¼šParaphrase å¡

### ç ”ç©¶ç›®çš„èˆ‡æ–¹æ³•
æœ¬ç ”ç©¶èšç„¦æ–¼7é ˜åŸŸï¼Œæ—¨åœ¨æ¢è¨ AI æŠ€è¡“åœ¨é†«ç™‚å ´æ™¯ä¸­çš„æ‡‰ç”¨ã€‚

### ä¸»è¦è²¢ç»
ç ”ç©¶æå‡ºäº†ä¸­ç­‰ï¼Œç‚ºè‡¨åºŠå¯¦è¸æä¾›äº†æ–°çš„è§£æ±ºæ–¹æ¡ˆã€‚

### æŠ€è¡“ç‰¹é»
- æ‡‰ç”¨å ´æ™¯ï¼š7
- å‰µæ–°ç¨‹åº¦ï¼šè©•åˆ† ä¸­ç­‰/10
- æœŸåˆŠå½±éŸ¿ï¼šç™¼è¡¨æ–¼ æœªçŸ¥æœŸåˆŠ

---

## â“ ç¬¬ä¸‰å¼µï¼šå•ç­”å¡

### Q1: é€™é …ç ”ç©¶è§£æ±ºäº†ä»€éº¼å•é¡Œï¼Ÿ
A: æœ¬ç ”ç©¶é‡å°7é ˜åŸŸçš„æŒ‘æˆ°ï¼Œæå‡ºäº†åŸºæ–¼ AI çš„è§£æ±ºæ–¹æ¡ˆã€‚

### Q2: æ¡ç”¨äº†ä»€éº¼æŠ€è¡“æ–¹æ³•ï¼Ÿ
A: ä¸­ç­‰

### Q3: ç ”ç©¶çš„ä¸»è¦æˆæœæ˜¯ä»€éº¼ï¼Ÿ
A: ç ”ç©¶ç²å¾—äº† ä¸­ç­‰ åˆ†çš„å°ˆå®¶è©•åˆ†ï¼Œè­‰æ˜äº†å…¶åœ¨7é ˜åŸŸçš„æ‡‰ç”¨åƒ¹å€¼ã€‚

### Q4: æœ‰å“ªäº›å¯¦éš›æ‡‰ç”¨å ´æ™¯ï¼Ÿ
A: ä¸»è¦æ‡‰ç”¨æ–¼7ï¼Œå¯ç”¨æ–¼æ”¹å–„é†«ç™‚æœå‹™å“è³ªå’Œæ•ˆç‡ã€‚

---

## ğŸ¤” ç¬¬å››å¼µï¼šä¾‹å¤–å¡

### æ½›åœ¨é™åˆ¶
1. **ç ”ç©¶ç¯„åœ**: ç ”ç©¶è©•åˆ†ç‚º ä¸­ç­‰/10ï¼Œå¯èƒ½å­˜åœ¨æ”¹é€²ç©ºé–“
2. **åœ°å€å·®ç•°**: ç ”ç©¶ä¾†è‡ªå¾…æŸ¥ï¼Œå…¶ä»–åœ°å€é©ç”¨æ€§éœ€é©—è­‰
3. **ROI æ•¸æ“š**: ç„¡æ•¸å€¼ï¼Œç¶“æ¿Ÿæ•ˆç›Šè©•ä¼°å¯èƒ½ä¸å®Œæ•´

### éœ€è¦é€²ä¸€æ­¥æ¢è¨çš„å•é¡Œ
1. è©²æŠ€è¡“åœ¨ä¸åŒè¦æ¨¡é†«é™¢çš„é©ç”¨æ€§å¦‚ä½•ï¼Ÿ
2. é•·æœŸä½¿ç”¨çš„æ•ˆæœå’Œç©©å®šæ€§æ˜¯å¦ç¶“éé©—è­‰ï¼Ÿ
3. èˆ‡ç¾æœ‰ç³»çµ±æ•´åˆæ™‚å¯èƒ½é¢è‡¨å“ªäº›æŒ‘æˆ°ï¼Ÿ

### æ‰¹åˆ¤æ€§æ€è€ƒ
- **æŠ€è¡“æˆç†Ÿåº¦**: éœ€è¦è©•ä¼°å¾ç ”ç©¶åˆ°å¯¦éš›éƒ¨ç½²çš„è·é›¢
- **æˆæœ¬æ•ˆç›Š**: ç„¡æ•¸å€¼ï¼Œéœ€è¦æ›´è©³ç´°çš„ç¶“æ¿Ÿåˆ†æ
- **å€«ç†è€ƒé‡**: AI åœ¨7æ‡‰ç”¨æ™‚çš„å€«ç†å’Œéš±ç§å•é¡Œ
- **å¯æ¨å»£æ€§**: ç ”ç©¶çµæœåœ¨å…¶ä»–é†«ç™‚å ´æ™¯çš„é©ç”¨æ€§

---

## ğŸ“š åƒè€ƒè³‡è¨Š
- **PMID**: [40815807](https://pubmed.ncbi.nlm.nih.gov/40815807/)
- **DOI**: https://doi.org/10.2196/69892
- **æœŸåˆŠ**: æœªçŸ¥æœŸåˆŠ
